Risk stratification for MDR/RR-TB: a comprehensive integrated patient-level analysis from TB programs and contemporary clinical trials
Researchers have developed a risk stratification model for multidrug-resistant tuberculosis to identify patients at higher risk of poor outcomes. By analyzing clinical factors like HIV status and BMI, the study demonstrates that personalized interventions can significantly improve treatment success rates.
Why it matters
This tool allows healthcare providers to tailor treatment regimens, potentially saving lives and optimizing resources for the world's deadliest infectious disease.
Nature Communications ( 2026 ) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in